Applied DNA Sciences (NASDAQ:APDN) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a research note published on Tuesday morning. The firm issued a sell rating on the technology company’s stock.

Separately, HC Wainwright cut their price target on Applied DNA Sciences from $7.00 to $1.50 and set a buy rating on the stock in a report on Monday, June 10th.

Applied DNA Sciences Stock Up 4.7 %

NASDAQ:APDN opened at $0.43 on Tuesday. Applied DNA Sciences has a 12-month low of $0.33 and a 12-month high of $37.20. The firm has a market capitalization of $416,500.00, a P/E ratio of -0.02 and a beta of 0.08. The stock’s fifty day simple moving average is $0.69 and its 200-day simple moving average is $6.29.

Applied DNA Sciences (NASDAQ:APDN) last posted its earnings results on Friday, May 10th. The technology company reported ($5.31) earnings per share for the quarter, missing the consensus estimate of ($4.60) by ($0.71). The business had revenue of $0.93 million for the quarter, compared to the consensus estimate of $0.90 million. Applied DNA Sciences had a negative return on equity of 306.32% and a negative net margin of 222.33%. As a group, equities research analysts expect that Applied DNA Sciences will post -2.95 earnings per share for the current year.

Institutional Trading of Applied DNA Sciences

A hedge fund recently raised its stake in Applied DNA Sciences stock. AMH Equity Ltd grew its position in Applied DNA Sciences, Inc. (NASDAQ:APDN) by 46.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 540,385 shares of the technology company’s stock after purchasing an additional 170,385 shares during the period. AMH Equity Ltd owned approximately 63.57% of Applied DNA Sciences worth $222,000 at the end of the most recent quarter. 22.22% of the stock is currently owned by institutional investors and hedge funds.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.